1. Home
  2. |Insights
  3. |New York State Employers Must Implement Their HERO Act Plans

New York State Employers Must Implement Their HERO Act Plans

Client Alert | 3 min read | 09.21.21

New York Governor Kathy Hochul announced on September 6, 2021, that the New York State Commissioner of Health has designated COVID-19 as a “highly contagious communicable disease that presents a serious risk of harm to the public health” under the New York State Health and Essential Rights Act (“HERO Act”).  Most employers in New York State must now promptly implement their airborne infectious disease exposure prevention plan (“Plan”) to ensure compliance. The New York State Department of Labor, as provided in the NY HERO Act Exposure Prevention Standard, has taken the position that employees and employers within the coverage of the Occupational Safety and Health Administration’s (“OSHA”) COVID-19 Healthcare Emergency Temporary Standard are not covered by these HERO Act mandates.

Covered employers were recently required to provide each employee in a New York State work site with a copy of their Plan in English or in the language identified as the primary language of such employee, if available, post a copy in a visible and prominent location within each New York State work site, and ensure that a copy of the Plan is accessible to employees during all work shifts. Based on this designation, pursuant to the Airborne Infectious Disease Exposure Prevention Standard, now an Emergency Regulation and proposed Final Regulation (“Standard”), employers must take the following actions in connection with their work sites in New York State:

  • Immediately review their Plan and update it, if necessary, to ensure that it incorporates current information, guidance, and mandatory requirements;
  • Finalize and promptly activate the Plan;
  • Provide employees a verbal review of their policies, employee rights under the applicable provisions of the HERO Act and the Plan. Such verbal review must be provided in a manner most suitable for the prevention of an airborne infectious disease, whether in person in a well-ventilated environment with appropriate face masks or personal protective equipment, or via audio or video conference technology, and
  • Designate one or more supervisory employees to enforce compliance with the Plan, the Standard and any other federal, state, or local guidance related to preventing the spread of the airborne infectious disease as applicable to employees and third parties within the workplace.

Employers must provide employees with a copy of their Plan within 30 days after adoption. As Gov. Hochul’s COVID-19 designation went into effect on September 6, employers should  distribute by October 6, 2021.

While this designation by the Commissioner of Health remains in effect, employers must ensure that the Plan for each work site in New York State is “effectively followed” by:

  • Assigning enforcement responsibilities to one or more supervisory employees;
  • Monitoring and maintaining exposure controls, and
  • Regularly checking for updated information and guidance provided by New York State Department of Health and the Centers for Disease Control and Prevention concerning the airborne infectious disease and updating their Plan when necessary.

While employers are confronting the continued threats of the delta variant of COVID-19, they should be mindful of recent developments such as President Biden’s comprehensive, six-part strategy to combat COVID-19, as addressed in our prior alert, along with other COVID-19 related requirements such as COVID-19 related paid sick and vaccination leaves. 

Insights

Client Alert | 5 min read | 12.12.25

Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality

On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument....